Molecular profiling of angiogenesis markers

被引:124
作者
Shih, SC
Robinson, GS
Perruzzi, CA
Calvo, A
Desai, K
Green, JE
Ali, IU
Smith, LEH
Senger, DR
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA
[2] NCI, Div Canc Prevent, NIH, Bethesda, MD 20892 USA
[3] NCI, Canc Res Ctr, NIH, Bethesda, MD 20892 USA
[4] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.1016/S0002-9440(10)64154-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The goal of this study was to develop a sensitive, simple, and widely applicable assay to measure copy numbers of specific mRNAs using real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), and identify a profile of gene expression closely associated with angiogenesis. We measured a panel of nine potential angiogenesis markers from a mouse transgenic model of prostate adenocarcinoma (TRAMP) and a mouse skin model of vascular endothelial growth factor (VEGF)-driven angiogenesis. In both models, expression of VEGF correlated with expression of mRNAs encoding other angiogenic cytokines (angiopoietin-1 and angiopoietin-2), endothelial cell receptor tyrosine kinases (Flt-1, KDR, Tie-1), and endothelial cell adhesion molecules (VE-cadherin, PECAM-1). Relative to control, in dermis highly stimulated by VEGF, the Ang-2 mRNA transcript numbers increased 35-fold, PECAM-1 and VE-cadherin increased 10-fold, Tie-1 increased 8-fold, KDR and Flt-1 each increased 4-fold, and Ang-1 increased 2-fold. All transcript numbers were correspondingly reduced in skin with less VEGF expression, indicating a relationship of each of these seven markers with VEGF. Thus, this study identifies a highly efficient method for precise quantification of a panel of seven specific mRNAs that correlate with VEGF expression and VEGF-induced neovascularization, and it provides evidence that real-time quantitative RT-PCR offers a highly sensitive strategy for monitoring angiogenesis.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 35 条
[1]   Detection and quantification of protein phosphatase inhibitor-1 gene expression in total rat liver and isolated hepatocytes [J].
Aleem, EA ;
Flohr, T ;
Hunziker, A ;
Mayer, D ;
Bannasch, P ;
Thielmann, HW .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2001, 217 (1-2) :1-12
[2]   Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization [J].
Asahara, T ;
Chen, DH ;
Takahashi, T ;
Fujikawa, K ;
Kearney, M ;
Magner, M ;
Yancopoulos, GD ;
Isner, JM .
CIRCULATION RESEARCH, 1998, 83 (03) :233-240
[3]   Molecular cloning and expression of murine vascular endothelial cadherin in early stage development of cardiovascular system [J].
Breier, G ;
Breviario, F ;
Caveda, L ;
Berthier, R ;
Schnurch, H ;
Gotsch, U ;
Vestweber, D ;
Risau, W ;
Dejana, E .
BLOOD, 1996, 87 (02) :630-641
[4]   Inhibition of cultured cell growth by vascular endothelial cadherin (Cadherin-5 VE-cadherin) [J].
Caveda, L ;
MartinPadura, L ;
Navarro, P ;
Breviario, F ;
Corada, M ;
Gulino, D ;
Lampugnani, MG ;
Dejana, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :886-893
[5]   Role of vascular endothelial growth factor in regulation of physiological angiogenesis [J].
Ferrara, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1358-C1366
[6]  
Folkman J, 1992, Semin Cancer Biol, V3, P89
[7]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[8]   Blood vessel formation: What is its molecular basis? [J].
Folkman, J ;
DAmore, PA .
CELL, 1996, 87 (07) :1153-1155
[9]   Peptide growth factors and prostate cancer: New models, new opportunities [J].
Foster, BA ;
Kaplan, PJ ;
Greenberg, NM .
CANCER AND METASTASIS REVIEWS, 1998, 17 (04) :317-324
[10]   Quantitative RT-PCR: Pitfalls and potential [J].
Freeman, WM ;
Walker, SJ ;
Vrana, KE .
BIOTECHNIQUES, 1999, 26 (01) :112-+